Due to the outbreak of COVID-19 in the country, lockdown and restrictions impacted consumers daily lives in France, causing ailments such as stress, insomnia and fatigue. This general psychological state also had an impact on consumers physical state, triggering or worsening certain skin pathologies such as eczema, psoriasis, acne, seborrheic dermatitis or even mycoses.
Many French men are increasingly concerned about losing their hair, with baldness said to impact 10 million French people in the country. Despite the trend for a natural appearance, products that fight against hair loss remain on a positive trend in 2020, although there was a slight slowdown in growth compared to previous years.
Johnson & Johnson Santé Beauté France continues to lead the extremely fragmented competitive landscape in 2020, followed by Bayer Sante Familiale SAS. Both players cover many types of dermatologicals with a large number of brands and products, with Bayer Sante Familiale SAS offering the leading product, Bepanthen.
Growth is set to increase in 2021 compared to 2020, with a strong increase seen in hair loss treatments and antiparasitics/lice (head and body) treatments. Hair loss treatment is predicted to recover from bad press seen in the review period, with both value and volume growth continuing to rise each year, as the demand for hair loss solutions grows.
Despite positive growth expected for antiparasitics/lice (head and body) treatments across the forecast period, emerging centres which treat lice have been developing in France. The mechanical process used in these centres was launched in France in 2015, and is regarded as being a more effective treatment solution, especially as louse are becoming more resistant to chemicals.
One of the main changes over the forecast period will be consumers ongoing switch towards more natural products, at the expense of dermatologicals with potentially noxious ingredients – for instance, corticoid-based creams. In nappy (diaper) rash treatments and paediatric dermatologicals, this can be seen in the “liniment” trend, with oleo-limestone liniment being a popular choice.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in France with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in France, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page